2 months ago
JNJ
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 27%
#1343 out of 5017 analysts
Average Return
+9.54%
Win Rate
68%15 out of 22
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +42.47% | $41.51 | $23.88 | 2024-12-10 - 2025-09-15 | Sell |
Abbvie IncABBV | +30.45% | $114.68 | $149.60 | 2021-05-03 - 2022-05-03 | Buy |
Regeneron Pharmaceuticals IncREGN | +26.45% | $778.50 | $572.59 | 2024-12-10 - 2025-09-15 | Sell |
Metsera IncMTSR | +25.17% | $27.33 | $34.21 | 2025-02-25 - 2025-09-15 | Strong Buy |
Moderna IncMRNA | +22.79% | $30.93 | $23.88 | 2025-02-11 - 2025-09-15 | Sell |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
5 months ago
JNJ
6 months ago
GILD
7 months ago
MRK
8 months ago
JNJ
8 months ago
JNJ
9 months ago
PFE
9 months ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $87.00 | +136.03% | Maintains | 19 days ago |
Metsera IncMTSR | 2 | Strong Buy | $50.00 | +46.16% | Maintains | 19 days ago |
Aardvark Therapeutics IncAARD | 3 | Strong Buy | $25.00 | +151.26% | Maintains | 19 days ago |
Pfizer IncPFE | 2 | Hold | $28.00 | +16.81% | Maintains | a month ago |
Amgen IncAMGN | 4 | Sell | $261.00 | -4.88% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 6 | Hold | $175.00 | -1.35% | Maintains | 2 months ago |
Abbvie IncABBV | 6 | Hold | $204.00 | -6.25% | Maintains | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 2 | Sell | $547.00 | -4.47% | Maintains | 5 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $126.00 | +11.96% | Maintains | 6 months ago |
Moderna IncMRNA | 2 | Sell | $34.00 | +42.38% | Maintains | 7 months ago |
Merck & Co IncMRK | 4 | Strong Buy | $112.00 | +38.24% | Maintains | 7 months ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $63.00 | +35.92% | Reinstates | 9 months ago |
Biogen IncBIIB | 1 | Hold | $178.00 | +24.20% | Reinstates | 9 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $997.00 | +33.25% | Reinstates | 9 months ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.